Literature DB >> 33945356

Splenic regression of amyloid on multi-modality imaging in response to treatment with patisiran and diflunisal in hereditary transthyretin amyloidosis.

Rishi K Patel1, Marianna Fontana1, Philip N Hawkins1, Julian Gillmore1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33945356     DOI： 10.1080/13506129.2021.1920389

Source DB:  PubMed          Journal:  Amyloid        ISSN： 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  1 in total

Review 1.  Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter Future.

Authors:  Laura Obici; Roberta Mussinelli
Journal:  Neurotherapeutics       Date:  2021-11-30       Impact factor: 6.088
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.